levity compounded semaglutide Demand Rising for 'Bootlegged' Weight-Loss Drug Levity shut it down :

Researchers studying the emerging field of triple agonism and glucagon's role in metabolic regulation may prefer retatrutide, the most novel compound of the three

And there was some interesting post-hoc analysis presented: When they looked at the age of the participants in the study, the researchers found that the under 60 years of age groupings had nominally significant decreased in the change from baseline in the sum of scores on MDS UPDRS parts II & III at 36 weeks were observed compared with placebo

Sources & References Eli Lilly

Decreased risk of anxiety in diabetic patients receiving glucagon-like peptide-1 receptor agonist: a nationwide, population-based cohort Study

This is my favorite pasta salad recipe

No more guessing